Ultra-efficient Amplification of Abnormal Prion Protein by Modified Protein Misfolding Cyclic Amplification with Electric Current
Authors:
Open Access
- 13 February 2017
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 55 (2) , 1630-1638
Abstract
Prion diseases are clinically diagnosed and confirmed upon post-mortem histopathological examination of brain tissue. The only reliable molecular marker for prion diseases is abnormal prion protein (PrPSc), a pathologically conformed prion protein that primarily accumulates in the central nervous system and to a lesser extent in lymphoreticular tissues. However, the use of PrPSc as a marker for preclinical diagnoses is limited because the concentration of PrPSc in easily accessible body fluids is extremely low. Hence, one of the most promising approaches would be the development of an efficient in vitro amplification method for PrPSc. Indeed, protein misfolding cyclic amplification (PMCA) has become an important diagnostic tool for prion diseases. Here, we first describe a new superior PMCA device that employs electricity (referred to as ePMCA) to amplify PrPSc. The ePMCA device markedly improved the detection limit for PrPSc by amplifying trace amounts of pathogenic prion protein by applying electricity to improve PMCA. To increase the cavitation of sonication, a glass sample tube was used, and the upper side of the horn was shaped such that it had a curved cross-section. The ePMCA device enabled PrPSc to be amplified even from a sample seeded with 10–28-fold diluted 263K scrapie-infected brain homogenates with recombinant hamster prion protein (rHaPrP). In addition, the efficiency of prion amplification was best when 50 mM HEPES and 1% Triton X-100 were used as a PMCA conversion buffer in the various conditions that we applied. These results indicate that ePMCA would be very valuable for the rapid and specific diagnosis of human prion diseases and, thus, may provide a practically improved method for antemortem diagnoses using the body fluids of patients and animals with prion disease.Keywords
Funding Information
- Korea Health Industry Development Institute (KHIDI) (HI16C0965010016)
This publication has 19 references indexed in Scilit:
- Prion-Seeding Activity in Cerebrospinal Fluid of Deer with Chronic Wasting DiseasePLOS ONE, 2013
- Highly Efficient Protein Misfolding Cyclic AmplificationPLOS Pathogens, 2011
- A novel method for preclinical detection of PrPSc in bloodJournal of General Virology, 2010
- Hyperefficient PrPSc amplification of mouse‐adapted BSE and scrapie strain by protein misfolding cyclic amplification techniqueThe FEBS Journal, 2009
- Urinary excretion and blood level of prions in scrapie-infected hamstersJournal of General Virology, 2007
- Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion proteinNature Methods, 2007
- Infectious Prions in the Saliva and Blood of Deer with Chronic Wasting DiseaseScience, 2006
- Generation of Monoclonal Antibody Recognized by the GXXXG Motif (Glycine Zipper) of Prion ProteinHybridoma, 2006
- Evaluation of urinary PrP Sc as a diagnostic test for sporadic, variant, and familial CJDNeurology, 2005
- Sensitive detection of pathological prion protein by cyclic amplification of protein misfoldingNature, 2001